Documente Academic
Documente Profesional
Documente Cultură
371
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
7.4 while the melting point is 52-57degree celcius. and mucoadhesive force were obtained by using
Poloxamers are used as emulsifying agents in simplex-lattice mixture design (Stat-Ease Design-
intravenous fat emulsions, and as solubilizing and Expert software-DX9). The nanogel networks offer
stabilizing agents to maintain the clarity of elixirs several advantages including prolonged drug release,
and syrups. Furthermore, it may also be used as excellent mucoadhesive properties, and
wetting agents; in ointments, suppository bases, and spreadability.
gels; and as tablet binders and coatings. Poloxamer
188 has been used as an emulsifying agent for MATERIALS
fluorocarbons and also used as artificial blood Erythromycin was gift sample from SM
substitutes and in the preparation of solid-dispersion Pharmaceuticals Sdn Bhd, Malaysia .Tween 20 was
systems. Poloxamer 188 is incompatible with purchased from R&M Chemical. Poloxamer 188
phenols and parabens depends on the relative was purchased from Merck KGaA (Darmstadt,
concentration [23]. In this paper, Erythromycin Germany). All water used in the formulation was of
nanogels with desired globule size, high gel strength Milli-pore grade.
METHOD OF PREPARATION: (Figure 1)
372
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
IN-VITRO EVALUATION Measurement was considered after reaching
Determination of pH: equilibrium.
The pH of the nanogels was determined by using a
calibrated PH meter (HANNA INS PH211). In-vitro permeation studies of nanogel formulations:
Measurements were considered after reaching In-vitro studies of the gel were carried out across the
equilibrium. The reading of all runs was noted. egg membrane extracted by using the concentrated
Viscosity studies: hydrochloric acid. The receptor compartments were
The viscosities of the various formulations were filled with phosphate buffered saline (PBS) pH 6.8,
determined by using Brookfield programmable DVII Study was carried out using excised egg membrane.
+Model pro II type (USA). The viscosity was noted The entire setup was placed on a thermostatic
in Centipoise [24]. magnetic stirrer and the temperature was maintained
Measurement of Spreadability: A small portion of at 37◦C throughout the study.
the nanogels was applied on a glass slide and was Permeability studies were carried out over a period
compressed to uniform thickness by placing 50 g for of 8 hrs at regular intervals. Samples were
5 minutes [25]. The time in which the upper glass withdrawn and analyzed spectrophotometrically at
slide move over the lower slide was taken as 264 nm.
measurement of spreadablility (S)
S= ML/T where, RESULT AND DISCUSSION
M= weight tide to upper slide (g) Optimization of process variables for the
L= length moved on the glass tide (cm) erythromycin nanogels:
T= time taken (sec) The effects of the three factors (Water, Oleic Acid
Measurement of gel strength: and Tween 20: Poloxamer 188) on the refractive
A sample of 50gm of nanogels was placed in a 100 index, globule size, gel strength, spreadability,
ml graduated. The apparatus for measuring gel mucoadhesive force and viscosity were tested.
strength (weighing 27 gm) was allowed to penetrate Through preliminary screening the water, oleic acid
in gel. The gel strength, which means the viscosity and surfactant/Co-surfactant ratio were identified as
of the nanogels was determined by the time the most significant variables within the range of 5-
(seconds), the apparatus took to sink 5cm down 7g, 1-3g and 1-3g, respectively. On the basis of the
through the prepared gel [26]. preliminary trials a simplex-lattice mixture design
Determination of mucoadhesive force: was employed to study the effect of each
The mucoadhesive force of nanogels was determined independent variable on dependent variables
as follows, a section of the chicken skin fixed with (refractive index, globule size, gel strength,
mucosal side out onto each glass vial using rubber spreadability, mucoadhesive force and viscosity). A
band. The vial with chicken skin was connected to simplex-lattice mixture design of degree m consists
the balance in inverted position while first vial was of m+1 points of equally spaced values between 0
placed on a height adjustable pan. Nanogels were and 1 for each component. If m = 2 then possible
added onto the skin of first vial. Then the height of fractions are 0, 1/2, 1. For m = 3 the possible values
second vial was so adjusted that the mucosal are 0, 1/3, 2/3, 1. The points include the pure
surfaces of both vials come in intimate contact. Two components and enough points between them to
minutes time of contact was given. Then weight was estimate an equation of degree m. This design differs
kept rising in the pan until vials get detached. from a simplex-centroid design by having enough
Mucoadhesive force was the minimum weight points to estimate a full cubic model. The
required to detach two vials. The chicken skin was independent factors and the dependent variables
changed for each measurement [25]. used in the design are listed in Table 1. The
Particle size analysis of nanogels: experiments were conducted as for the design of
Particle size of nanoparticles was determined using experiments and the responses for the dependent
malvern particle size analyzer (Zetasizer 4000S, variables were entered in Table 2. The response
Japan). surfaces of the variables inside the experimental
Determination of refractive index: domain were analyzed using Stat-Ease Design-
The refractive index of nanogels was determined by Expert software (DX9). Subsequently, three
using Lan Optics. A small portion of samples were additional confirmation experiments were conducted
placed on the glass slide of the equipment. The to verify the validity of the statistical experimental
refractive index will be shown by the equipment. strategies.
373
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
Table-1: List of Independent variable and Dependent variables in simplex-lattice mixture design
Independent variable Levels
Variable Name Units Low Middle High
A Surfactant % 5 7
B Speed rpm 5000 6500 8000
C Time time 60 120 180
Dependent variable Goal
Y1 Refractive index
Y2 Globule size
Y3 Gel strength
Y4 Spreadability Optimized value
Y5 Mucoadhesive force
Y6 Viscosity
Mathematical relationship generated using multiple linear regression analysis for the studied variables are
expressed as shown in Table 3.
Table 3: Multiple linear regression analysis
Y1 +1.36 A+1.39 B+1.39 C-0.022 AB+7.085 AC-0.027 BC-0.050 ABC
Y2 +245.91A+212.91 B+188.91 C+3.62AB+36.86 AC-45.14 BC-2698.81 A2BC
-394.81AB2C+818.01 ABC2
Y3 +30.06 A+19.78 B+98.65 C-61.42 AB-165.91 AC+132.38 BC
Y4 +11.43 A+17.98 B+13.27 C+178.57 AB+204.06 AC-53.17 BC-3222.27A2BC+1017.63 AB2C-
1028.63 ABC2
Y5 +20750.64 A+15951.93 B+28764.12 C-9268.19 AB-34314.40 AC+32494.26 BC-1.598 A2BC-
5.020 AB2C+3.90ABC2
Y6 +111.50 A+77.35 B+411.55 C-80.92 AB-687.35 AC+959.35 BC-18663.79 A2BC -26790.79
AB2C+41523.11 ABC2
374
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
The quartic mixture model represent the
quantitative effect of Water (A), Oil (B) and ratio
of surfactant: Co-surfactant (C) and their
interaction on Refractive index (Y1), Globule size
(Y2), Gel strength (Y3), Spreadability (Y4),
Mucoadhesive force (Y5) and Viscosity (Y6). The
values of the coefficient A, B and C are related to
the effect of these variables on the responses Y1 to
Y6. Coefficients with more than one factor term
and those with higher order terms represent
interaction terms and quadratic relationship
respectively. A positive sign represents a
synergistic effect, while a negative sign indicates an
antagonistic effect. A backward elimination
procedure was adopted to fit the data to the
quadratic mixture model. Both the polynomial
equations were found to be statistically significant
(P <0.01), as determined using ANOVA, as per the
provision of Design Expert software (DX9). Figure 2: Trace graph (piepel) shows the main
Refractive index of erythromycin nanogels was effect of water (A), oil (B) and surfactant: Co-
found to be in the range of 1.371– 1.395 as shown surfactant ratio (C) on refractive index.
in Table 2. The factorial equation for refractive
index exhibited a good correlation coefficient
(1.000) and the Model F-value of 771.58 implies
the model is significant. There is only a 0.01%
chance that an F-value this large could occur due to
noise. Values of "Prob > F" less than 0.0500
indicate model terms are significant. In this case A,
B, C, AB, AC, BC, ABC are significant model
terms. All the three variables having the positive
effect on the refractive index, which means these
factors, are directly proportional to the response.
The influence of the main and interactive effects of
independent variables on the refractive index was
further elucidated using the perturbation and 3D
response surface plots. The individual main effects
of A, B and C on particle size are as shown in
Figure 2. It is found that all the variables are having
interactive effects for the response Y1. The trace
graph (piepel), 2D contour, 2D real contour and 3D
response surface plots of the response Y1 are Figure 3: Response 2D contour plot represents
shown in Figure 2, 3, 4 and 5 to depict the the interaction between the water, oil and
interactive effects of independent variables on surfactant: Co-surfactant ratio affecting the
response Y1. refractive index.
375
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
this case A, B, C, A2BC are significant model
terms. It was found that all the variables are having
interactive effects for the response Y2. The trace
graph (piepel), 2D contour, 2D real contour and 3D
response surface of the response Y2 were shown in
figure 6, 7, 8 and 9 to depict the interactive effects
of independent variables on globule size. During
erythromycin nanogels preparation, we sonicated
the emulsion for 5 min using a probe sonicator set
at 50 Amplitude power. As a result, we achieved a
size under 250 nm globule sizes shown in figure 10.
377
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
378
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
380
Research article Rapports De Pharmacie Vol.3 (2), 2017, 371-383
ISSN: 2455-0507
100.0
95
90
3901.63
3838.35
3916.38
3776.76
85
3990.33
3978.82
80
75
1935.98
1998.25
70 2501.66
2552.95 556.49
2522.26
2341.86
65
60
1567.06 502.84
55 1776.19
3618.08 1507.79
3054.61
50 3593.81
807.65
760.76
786.25
832.53
751.39
719.55
45 774.80
647.90 426.75
%T
40
2791.10
2783.41
909.53
35 3016.03
893.55
2832.82
30
25
3361.85
3314.86
1318.00
20 3346.51
3513.01 1237.13
1474.05
1426.05
3493.82 1725.87
15 1460.58
1412.22 1266.22 946.99
3333.21
2992.13 1450.01
10 2950.89 1399.92
1339.10 984.31
3389.05 1351.75 1025.61
996.07
973.38
1201.08
5
0 2975.08
1174.46
1049.63
-5
3464.00
3428.50
3401.50 1374.50 1167.17
1132.00
1117.00
1088.50
1155.50
1148.50 1065.00
1071.39 961.50
-10.0
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
95
90
85
80
720.32
75 1783.18
3831.87
3873.06
3818.29
3799.31
70
2521.12 2314.36 746.22
2083.03
65 2335.38
758.38
2143.35
60
2243.05
2168.76
55 594.97
3100.08
781.89
3081.85
50
1626.25
45
%T
40 862.44
878.24 607.30
651.60
639.15
1967.95 988.18
35
3258.40
1406.34
30 1381.67
802.45 617.76
25 971.04
3323.51 1390.47
3310.58
3420.73
3297.35 2706.77
20 3278.60 1367.30 1171.56
3455.71 1459.67 1336.70 1123.44
3609.33 3359.26
1047.14 826.74
15 1155.14
1094.98
1029.83
1068.75
1258.87
10 3541.80
3588.31
3493.73
3476.70 2783.10
2799.10
1103.75
5 1061.71
838.07
927.08
0
1082.45 819.67
2950.03
2934.02 543.56
-5 2899.47 937.70 846.53
2966.00 953.00 515.50
-10.0
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
95
90
85
80
75
70
3802.26
3852.94
3838.00
65
2437.46
2415.20
60
2356.13
55
50 2186.69
2165.93
45 2207.87
850.94
%T
40 1539.97
2649.33 1965.60
35
1523.10 891.18
30 829.96
879.89
1605.74
735.10
25 1049.35
3613.09
3173.10
1034.98
1061.54
20 3181.19
3597.40 3198.56
700.97
870.92
3405.15
15
3582.27
1725.28 650.46
3317.55 1415.89
10 3213.90 1738.82
1456.02 1334.65 1023.32 661.64
3282.64 1233.16
3265.29
3226.34
3293.37 2997.21 686.82
3522.763359.81
5 945.60
3306.85 1135.21
3247.24 2879.76
1281.56
1253.05 1163.91
0 1144.13
3446.77 2869.92 1661.89 1001.48
2962.82
2981.38 1347.19
-5 2910.65 861.15
3376.01
3558.00
3543.00
3536.50
3422.00
3416.00
3388.503237.50 2972.50
2895.00 1387.00
1375.00
1362.50 983.50
965.50 672.00 528.50
-11.8
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
381
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
90
80
70
60
% CDR
50
Run 6
40
Run 7
30
20
10
0
1 2 3 4 5 6 7 8 9
Time in hours
Figure-26: Showing the percentage of drug release
As depicted in Figure 23, 24 and 25 the FT-IR [2] D Peer, JM Karp, S Hong, OC Farokhzad, R
spectra of erythromycin revealed high intensity Margalit, R Langer. Nanocarriers as an
broad bands at approximately 2975.08, 2341.86, emerging platform for cancer therapy. Nat.
1998.25 and 1725.87 cm−1. These peaks have also Nanotechnol. 2:751–760 (2007).
been observed in a physical mixture of drug and [3] N Wiradharma, Y Zhang, S Venkataraman,
poloxamer 188 peaks at 2972.02, 2356.13, 1965.60 JL Hedrick, YY Yang, Self-assembled
and 1725.28 cm−1. polymer nanostructures for delivery of
Run 6 and Run 7 were selected according to anticancer therapeutics. Nano Today 4: 302–
spreadability values. The in vitro release profile of 317 (2009).
nanogels in PBS (pH = 6.8) is shown in Fig. 26. [4] L Brannon-Peppas, JO Blanchette,
Drug release at the end of 8 hours (approximately Nanoparticle and targeted systems for
81.3 and 82.4 %) cancer therapy, Adv. Drug Deliv. Rev.
CONCLUSION 64:206–212 (2012).
Erythromycin nanogels were prepared by using [5] M Elsabahy, KLWooley, Design of
probe sonicator. The application of factorial design polymeric nanoparticles for biomedical
gave a statistically systematic approach for the delivery Applications. Chem. Soc. Rev.
formulation of nanogels with ideal particle size. Oil 41:2545–2561(2012).
phase, water phase and surfactant: Cosurfactant [6] R Haag, F Kratz. Polymer therapeutics:
ratios were found to influence the globule size, concepts and applications. Angew. Chem.
refractive index, gel strength, spreadability, Int. Ed. 45:1198–1215 (2006).
mucoadhesive force and viscosity of erythromycin [7] TM Allen, PR Cullis. Drug delivery
loaded nanogels. In vitro drug release study of systems: entering the mainstream, Science
selected factorial formulations (run 6 and run 7) 303: 1818–1822 (2004).
showed 81.3 % and 82.4% release respectively at [8] RT Chacko, J Ventura, J Zhuang, S
the end of 8 hours. The overall results suggest that Thayumanavan. Polymer nanogels: a
erythromycin loaded nanogels could be a potential versatile nanoscopic drug delivery platform.
option for topical delivery. Adv. Drug Deliv. Rev. 64: 836–851 (2012).
[9] L Zha, B Banik, F Alexis. Stimulus
REFERENCE responsive nanogels for drug delivery. Soft
[1] ME Davis, Z Chen, DM Shin, Nanoparticle Matter7 5908–5916 (2011).
therapeutics: an emerging treatment [10] AV Kabanov, SV Vinogradov. Nanogels as
modality for cancer. Nat. Rev. Drug Discov. pharmaceutical carriers: finite networks of
7:771–782 (2008). infinite capabilities. Angew. Chem. Int. Ed.
48: 5418–5429 (2009).
382
Lim Kuan Ting et al,: Optimization and in-vitro characterization of erythromycin nanogels
[11] EA Murphy, BK Majeti, R Mukthavaram, and capsules for integrated multifunctional
LM Acevedo, LA Barnes, DA Cheresh. intelligent systems. Prog Polym Sci. 35:
Targeted nanogels: a versatile platform for 174-211 (2010).
drug delivery to tumors. Mol. Cancer [20] MAC Stuart, WT Huck, J Genzer, M
Ther. 10: 972–982 (2011). Müller, C Ober, M Stamm, et al. Emerging
[12] G Liu, Z An. Frontiers in the design and applications of stimuli-responsive polymer
synthesis of advanced nanogels for materials. Nat Mater. 9:101-113 (2010).
Nanomedicine. Polym. Chem. 5:1559–1565 [21] JK Oh, R Drumright, DJ Siegwart, K
(2014). Matyjaszewski. The development of
[13] Y Jiang, J Chen, C Deng, EJ Suuronen, Z microgels/nanogels for drug delivery
Zhong. Click hydrogels, microgels and applications. Prog Polym Sci. 33:448-
nanogels: emerging platforms for drug 477(2008).
delivery and tissue engineering. [22] C Solans, P Izquierdo, J Nolla, N. Azemar,
Biomaterials 35:4969–4985 (2014). MJ Garcia-Celma, Nano-emulsions. Curr.
[14] FR Kersey, TJ Merkel, JL Perry, ME Opin. Colloid Interface Sci. 10:102–110
Napier, JM DeSimone. Effect of aspect ratio (2005).
and deformability on nanoparticle [23] http://pharmaenfo.com/Excipients/excipient
extravasation through nanopores. Langmuir. Detail/Poloxamer
28:8773-8781 (2012). [24] Liow HinTeng, Jaya Raja Kumar,
[15] AV Kabanov, SV Vinogradov. Nanogels as LeenaiLeng, MVRA Maivizhi Selvi, R
pharmaceutical carriers: finite networks Kanagambikai. Nanoparticle loaded
of infinite capabilities. Angew Chem Int Ed. thermosensitive nasal in-situ gels for
48:5418-5429 (2009). delivery of loratadine: in- vitro & in-vivo
[16] VP Torchilin. Multifunctional, stimuli- evaluation studies. Rapports De
sensitive nanoparticulate systems for drug Pharmacie.1:17-27(2015).
Delivery. Nat Rev Drug Discov. 13:813- [25] MVRA MaivizhiSelvi, Jaya Raja Kumar, R
827(2014). Kanagambikai, Lee Ali Leng, LiowHin
[17] L Zha, B Banik, F Alexis. Stimulus Teng. In-vitro and in-vivo evaluation of
responsive nanogels for drug delivery. Soft nanoparticles loaded temperature induced
Matter. 7: 5908-5916 (2011). oral gel drug delivery system of acyclovir.
[18] S Mura, J Nicolas, P Couvreur. Stimuli- Rapports De Pharmacie.1 (2):81-89 (2015).
responsive nanocarriers for drug delivery. [26] Jaya raja Kumar, Selvadurai Muralidharan,
Nat Mater. 12: 991-1003 (2013). V Vijayan. Development and
[19] M Motornov, Y Roiter, I Tokarev, S Minko. pharmacological evaluations of econazole
Stimuli-responsive nanoparticles, nanogels nitrate microsperes enriched gel. Rapports
De Pharmacie. 1(1):32-38 (2015).
383